Aug 1, 2019 Issue
Should Adults with Prediabetes Be Prescribed Metformin to Prevent Diabetes Mellitus? Yes: High-Quality Evidence Supports Metformin Use in Persons at High Risk [Editorials: Controversies in Family Medicine]

High-quality evidence supports metformin use for diabetes prevention among younger or more obese individuals or for women with a history of gestational diabetes. Clinicians should consider prescribing metformin, in addition to intensive lifestyle interventions, in accordance with patients' values and preferences.

Aug 1, 2019 Issue
Asthma, PAD and Cardiovascular Disease, Persons Who Inject Drugs, Crohn’s Disease, Insulin Analogs [AFP Clinical Answers]

Key clinical questions and their evidence-based answers directly from the journal’s content, written by and for family physicians.

Jul 15, 2019 Issue
Semaglutide (Ozempic) for Type 2 Diabetes Mellitus [STEPS]

Semaglutide can be added to existing treatment to improve glycemic control and induce weight loss. It may also protect against cardiovascular outcomes in patients with type 2 diabetes and established cardiovascular disease.

Jul 15, 2019 Issue
Omega-3 Oil Does Not Reduce Serious Cardiovascular Events for Patients with Diabetes Mellitus [POEMs]

In this study, there was no significant difference in the likelihood of a composite vascular outcome or all-cause mortality in patients given an omega-3 fatty acid supplement compared with those given an olive oil placebo.

Jun 15, 2019 Issue
Diabetic Kidney Disease: Diagnosis, Treatment, and Prevention [Article]

Diabetic kidney disease (DKD) is associated with higher cardiovascular and all-cause morbidity and mortality. Screening is best done with annual spot urine albumin/creatinine ratio testing. Treatment includes management of hyperglycemia, hypertension, hyperlipidemia, and cessation of tobacco use. Blood pressure should be monitored. Several medications may help prevent or slow progression of DKD. Patients who progress to at least stage 3 DKD may benefit from referral to nephrology subspecialists.

Jun 1, 2019 Issue
Benefits and Harms for Low-Dose Aspirin in Patients with Diabetes Mellitus [POEMs]

The 7,740 patients who took low-dose aspirin experienced 51 fewer vascular deaths, nonfatal myocardial infarctions, or nonfatal ischemic strokes; 29 fewer transient ischemic attacks; and 44 fewer revascularizations than patients who took placebo over a mean of 7.4 years.

Apr 1, 2019 Issue
Understanding the High Cost of Insulin: What Family Physicians Can Do to Help Our Patients with Type 2 Diabetes Mellitus [Editorials]

Through clinical and system-level interventions, family physicians can push back against the high cost of insulin and help patients with type 2 diabetes afford these essential medications.

Mar 15, 2019 Issue
Osteoporosis, Childhood Bullying, Rheumatoid Arthritis, Diabetes Counseling, Inhaled Steroids [AFP Clinical Answers]

Key clinical questions and their evidence-based answers directly from the journal’s content, written by and for family physicians.

Feb 15, 2019 Issue
Type 2 Diabetes Therapies: A STEPS Approach [Article]

The first-line treatment option for type 2 diabetes mellitus, metformin, is safe and fairly well-tolerated, has excellent long-term effectiveness on patient-oriented outcomes, is moderately priced, and has a simple dosing regimen. When more than one medication is required, the STEPS approach can help choose subsequent medications.

Jan 1, 2019 Issue
NPH Insulin: Fewer Episodes of Severe Hypoglycemia Than Analogs and Less Than One-Half the Cost [POEMs]

This study found that compared with expensive long-acting insulin analogs costing two to 10 times as much, NPH insulin results in a similar number of episodes of severe hypoglycemia (if not fewer) that result in emergency department visits and hospitalizations.

Pages: Previous 1 2 3 4 5 6 7 8 9 10 ... 19 Next

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now